Guanylate Cyclases Antibodies

Santa Cruz Biotechnology features a diverse variety of Guanylate Cyclases monoclonal antibodies for investigating guanylate cyclases in various biological processes. Guanylate Cyclases Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Guanylate cyclases are essential enzymes that catalyze the conversion of GTP to cyclic GMP, a key signaling molecule involved in numerous physiological processes such as vasodilation, neurotransmission, and cell proliferation. Dysregulation of guanylate cyclases has been implicated in various diseases, making them important targets for therapeutic intervention. Research focused on guanylate cyclases continues to reveal new insights into cardiovascular health, neurobiology, and cancer development. Scientists worldwide rely on high-quality monoclonal antibodies to advance their understanding of guanylate cyclase functions and regulatory mechanisms. Investigating guanylate cyclases can lead to breakthroughs in disease treatment and prevention strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to conduct precise experiments that contribute to scientific advancement in cellular signaling pathways.